Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group

Archie Bleyer, Mehee Choi, Samuel Wang, Clifton D. Fuller, R. Beverly Raney

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose. To assess the rate of spinal cord toxicity in adolescents resulting from chemoradiotherapy of parameningeal sarcoma. Methods and Materials. Of 152 patients with parameningeal sarcoma treated per the Intergroup Rhabdomyosarcoma Study Group protocol from 1977 through 1989, eight developed paralyzing ascending myelitis after intrathecal chemotherapy with cytosine arabinoside, methotrexate, and hydrocortisone administered during and after radiation therapy to volumes that included part of the spinal cord. The eight cases include three not previously published. Results. Of eight patients who developed CNS toxicity after intrathecal chemotherapy and radiotherapy for parameningeal rhabdomyosarcoma, all but one were between 13 and 18 years of age when treated. This severe toxicity occurred in one quarter of 28 adolescents treated with the regimen in comparison with one of 123 children 12 years of age or less (P

Original languageEnglish (US)
Pages (from-to)1205-1210
Number of pages6
JournalPediatric Blood and Cancer
Volume53
Issue number7
DOIs
StatePublished - Dec 15 2009

Fingerprint

Rhabdomyosarcoma
Sarcoma
Spinal Cord
Radiotherapy
Radiation
Myelitis
Drug Therapy
Cytarabine
Chemoradiotherapy
Methotrexate
Hydrocortisone

Keywords

  • Adolescence
  • Intrathecal chemotherapy
  • Radiation myelopathy
  • Sarcoma
  • Spinal cord

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this

Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence : A report from the Children's Oncology Group. / Bleyer, Archie; Choi, Mehee; Wang, Samuel; Fuller, Clifton D.; Raney, R. Beverly.

In: Pediatric Blood and Cancer, Vol. 53, No. 7, 15.12.2009, p. 1205-1210.

Research output: Contribution to journalArticle

Bleyer, Archie ; Choi, Mehee ; Wang, Samuel ; Fuller, Clifton D. ; Raney, R. Beverly. / Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence : A report from the Children's Oncology Group. In: Pediatric Blood and Cancer. 2009 ; Vol. 53, No. 7. pp. 1205-1210.
@article{eb17549085374f4891a02b6a2a7c2d00,
title = "Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group",
abstract = "Purpose. To assess the rate of spinal cord toxicity in adolescents resulting from chemoradiotherapy of parameningeal sarcoma. Methods and Materials. Of 152 patients with parameningeal sarcoma treated per the Intergroup Rhabdomyosarcoma Study Group protocol from 1977 through 1989, eight developed paralyzing ascending myelitis after intrathecal chemotherapy with cytosine arabinoside, methotrexate, and hydrocortisone administered during and after radiation therapy to volumes that included part of the spinal cord. The eight cases include three not previously published. Results. Of eight patients who developed CNS toxicity after intrathecal chemotherapy and radiotherapy for parameningeal rhabdomyosarcoma, all but one were between 13 and 18 years of age when treated. This severe toxicity occurred in one quarter of 28 adolescents treated with the regimen in comparison with one of 123 children 12 years of age or less (P",
keywords = "Adolescence, Intrathecal chemotherapy, Radiation myelopathy, Sarcoma, Spinal cord",
author = "Archie Bleyer and Mehee Choi and Samuel Wang and Fuller, {Clifton D.} and Raney, {R. Beverly}",
year = "2009",
month = "12",
day = "15",
doi = "10.1002/pbc.22164",
language = "English (US)",
volume = "53",
pages = "1205--1210",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence

T2 - A report from the Children's Oncology Group

AU - Bleyer, Archie

AU - Choi, Mehee

AU - Wang, Samuel

AU - Fuller, Clifton D.

AU - Raney, R. Beverly

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Purpose. To assess the rate of spinal cord toxicity in adolescents resulting from chemoradiotherapy of parameningeal sarcoma. Methods and Materials. Of 152 patients with parameningeal sarcoma treated per the Intergroup Rhabdomyosarcoma Study Group protocol from 1977 through 1989, eight developed paralyzing ascending myelitis after intrathecal chemotherapy with cytosine arabinoside, methotrexate, and hydrocortisone administered during and after radiation therapy to volumes that included part of the spinal cord. The eight cases include three not previously published. Results. Of eight patients who developed CNS toxicity after intrathecal chemotherapy and radiotherapy for parameningeal rhabdomyosarcoma, all but one were between 13 and 18 years of age when treated. This severe toxicity occurred in one quarter of 28 adolescents treated with the regimen in comparison with one of 123 children 12 years of age or less (P

AB - Purpose. To assess the rate of spinal cord toxicity in adolescents resulting from chemoradiotherapy of parameningeal sarcoma. Methods and Materials. Of 152 patients with parameningeal sarcoma treated per the Intergroup Rhabdomyosarcoma Study Group protocol from 1977 through 1989, eight developed paralyzing ascending myelitis after intrathecal chemotherapy with cytosine arabinoside, methotrexate, and hydrocortisone administered during and after radiation therapy to volumes that included part of the spinal cord. The eight cases include three not previously published. Results. Of eight patients who developed CNS toxicity after intrathecal chemotherapy and radiotherapy for parameningeal rhabdomyosarcoma, all but one were between 13 and 18 years of age when treated. This severe toxicity occurred in one quarter of 28 adolescents treated with the regimen in comparison with one of 123 children 12 years of age or less (P

KW - Adolescence

KW - Intrathecal chemotherapy

KW - Radiation myelopathy

KW - Sarcoma

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=70449723302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449723302&partnerID=8YFLogxK

U2 - 10.1002/pbc.22164

DO - 10.1002/pbc.22164

M3 - Article

C2 - 19821538

AN - SCOPUS:70449723302

VL - 53

SP - 1205

EP - 1210

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -